Onderneming MolMed S.p.A.
Aandelen
MLM
IT0001080248
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 31-07-20 | |
Kasper Møller
CTO | Chief Tech/Sci/R&D Officer | - | - |
Greg Shelton
HRO | Human Resources Officer | - | 01-07-21 |
Alberto Sobrero
PRN | Corporate Officer/Principal | - | - |
Robert Kerbel
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 01-01-20 | |
Corporate Officer/Principal | - | 01-11-21 | |
Luca Alberici
PRN | Corporate Officer/Principal | - | 01-01-06 |
Riccardo Perotta
AUD | Comptroller/Controller/Auditor | 75 | - |
Catia Traversari
PRN | Corporate Officer/Principal | - | 01-01-02 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 31-07-20 | |
Fabio Scoyni
CHM | Chairman | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 463 450 672 | 30 671 165 ( 6,618 %) | 0 | 6,618 % |
Bedrijfsgegevens
![Adres MolMed S.p.A.(MLM)](https://cdn.zonebourse.com/static/address/2178402.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,65% | 39,36 mld. | |
-8,62% | 38,52 mld. | |
+26,95% | 30,74 mld. | |
+10,74% | 25,92 mld. | |
-13,50% | 26,03 mld. | |
+44,87% | 14,13 mld. | |
+34,36% | 12,73 mld. | |
-7,14% | 11,29 mld. | |
-12,61% | 10,64 mld. |